| NCT ID | NCT06476886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jennifer Hughes |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 213 participants |
| Start Date | 2024-06-03 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 213 participants in total. It began in 2024-06-03 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study's purpose is to improve the clinical management of severe crises experienced by youth with psychiatric disorders by examining a brief, evidence-based alternative to inpatient psychiatric care.
Eligibility Criteria
Inclusion Criteria: 1. Youth between the ages of 12 years 0 months and 17 years 6 months at time of consent 2. Present to the Nationwide Children's Hospital (NCH) Psychiatric Crisis Department (PCD) or NCH Psychiatry Consult Liaison (CL) Service with suicidal ideation and/or behavior as the primary referral 3. Be eligible for admission to both YCSU and APIU based on PCD or CL clinician's clinical judgement 4. Patient and legal guardian must be willing to be admitted to either YCSU or APIU 5. Youth obtains a score of ≥23 on the Concise Health Risk Tracking Self-Report (CHRT-SR) 6. Youth resides with a primary caretaker who has legal authority to consent for participation in research 7. Legal guardian must attend the PCD or CL evaluation Exclusion Criteria: 1. Participants who are unable to understand study procedures (e.g., intellectual disability, actively psychotic) 2. Inability to speak or read English adequately to understand and complete study consent and procedures YCSU clinicians, PCD staff, and NCH-BH leaders will be invited to participate based on their roles in the system-of-care.
Contact & Investigator
Jennifer L Hughes
PRINCIPAL INVESTIGATOR
Nationwide Children's Hospital
Frequently Asked Questions
Who can join the NCT06476886 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06476886 currently recruiting?
Yes, NCT06476886 is actively recruiting participants. Contact the research team at jennifer.hughes@nationwidechildrens.org for enrollment information.
Where is the NCT06476886 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT06476886 clinical trial?
NCT06476886 is sponsored by Jennifer Hughes. The principal investigator is Jennifer L Hughes at Nationwide Children's Hospital. The trial plans to enroll 213 participants.